BACD - Accounts to registrar (filleted) - small 18.2

BACD - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.1.65 06634531 Board of Directors Board of Directors 1.7.17 30.6.18 30.6.18 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure066345312017-06-30066345312018-06-30066345312017-07-012018-06-30066345312016-06-30066345312016-07-012017-06-30066345312017-06-3006634531ns15:EnglandWales2017-07-012018-06-3006634531ns14:PoundSterling2017-07-012018-06-3006634531ns10:Director12017-07-012018-06-3006634531ns10:Director22017-07-012018-06-3006634531ns10:CompanyLimitedByGuarantee2017-07-012018-06-3006634531ns10:SmallEntities2017-07-012018-06-3006634531ns10:AuditExempt-NoAccountantsReport2017-07-012018-06-3006634531ns10:SmallCompaniesRegimeForDirectorsReport2017-07-012018-06-3006634531ns10:SmallCompaniesRegimeForAccounts2017-07-012018-06-3006634531ns10:FullAccounts2017-07-012018-06-300663453112017-07-012018-06-3006634531ns10:Director42017-07-012018-06-3006634531ns10:Director52017-07-012018-06-3006634531ns10:Director72017-07-012018-06-3006634531ns10:Director82017-07-012018-06-3006634531ns10:CompanySecretary12017-07-012018-06-3006634531ns10:RegisteredOffice2017-07-012018-06-3006634531ns5:CurrentFinancialInstruments2018-06-3006634531ns5:CurrentFinancialInstruments2017-06-3006634531ns5:FurtherSpecificReserve1ComponentTotalEquity2018-06-3006634531ns5:FurtherSpecificReserve1ComponentTotalEquity2017-06-3006634531ns5:RetainedEarningsAccumulatedLosses2018-06-3006634531ns5:RetainedEarningsAccumulatedLosses2017-06-3006634531ns5:IntangibleAssetsOtherThanGoodwill2017-07-012018-06-3006634531ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2017-07-012018-06-3006634531ns5:ComputerSoftware2017-07-012018-06-3006634531ns5:PlantMachinery2017-07-012018-06-3006634531ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2017-06-3006634531ns5:ComputerSoftware2017-06-3006634531ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-06-3006634531ns5:ComputerSoftware2018-06-3006634531ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2017-06-3006634531ns5:ComputerSoftware2017-06-3006634531ns5:PlantMachinery2017-06-3006634531ns5:PlantMachinery2018-06-3006634531ns5:PlantMachinery2017-06-3006634531ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-06-3006634531ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-06-30


REGISTERED NUMBER: 06634531 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2018

FOR

BACD
T/A
BRITISH COLLEGE OF AESTHETIC MEDICINE

BACD (REGISTERED NUMBER: 06634531)
T/A BRITISH COLLEGE OF AESTHETIC MEDICINE

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BACD
T/A BRITISH COLLEGE OF AESTHETIC MEDICINE

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2018







DIRECTORS: Dr P Myers
Dr P B Charlson
Dr K Long
Dr R J Harker
Dr U Gout
Dr C O J Coffey





SECRETARY: Dr P.A. Dobson





REGISTERED OFFICE: Shorne Village Surgery
Crown Lane
Shorne
Kent
DA12 3DY





REGISTERED NUMBER: 06634531 (England and Wales)





ACCOUNTANTS: The Carley Partnership
St James's House
8 Overcliffe
Gravesend
Kent
DA11 0HJ

BACD (REGISTERED NUMBER: 06634531)
T/A BRITISH COLLEGE OF AESTHETIC MEDICINE

BALANCE SHEET
30 JUNE 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 190 223
190 223

CURRENT ASSETS
Debtors 6 66,595 10,714
Cash at bank and in hand 486,920 511,325
553,515 522,039
CREDITORS
Amounts falling due within one year 7 147,339 157,898
NET CURRENT ASSETS 406,176 364,141
TOTAL ASSETS LESS CURRENT
LIABILITIES

406,366

364,364

RESERVES
Funding reserves 14,257 14,257
Income and expenditure account 392,109 350,107
406,366 364,364

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 26 November 2018 and were signed on its behalf
by:



Dr P B Charlson - Director



Dr R J Harker - Director


BACD (REGISTERED NUMBER: 06634531)
T/A BRITISH COLLEGE OF AESTHETIC MEDICINE

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018


1. STATUTORY INFORMATION

BACD is a private company, limited by guarantee , registered in England and Wales. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Computer software is being amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 15% on reducing balance

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to surplus or deficit on a straight line basis over the period of the
lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2017 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Development Computer
costs software Totals
£    £    £   
COST
At 1 July 2017
and 30 June 2018 126,500 8,750 135,250
AMORTISATION
At 1 July 2017
and 30 June 2018 126,500 8,750 135,250
NET BOOK VALUE
At 30 June 2018 - - -
At 30 June 2017 - - -

BACD (REGISTERED NUMBER: 06634531)
T/A BRITISH COLLEGE OF AESTHETIC MEDICINE

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2018


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 July 2017
and 30 June 2018 990
DEPRECIATION
At 1 July 2017 767
Charge for year 33
At 30 June 2018 800
NET BOOK VALUE
At 30 June 2018 190
At 30 June 2017 223

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Other debtors 66,595 10,714

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade creditors - 105
Taxation and social security 6,743 4,284
Other creditors 140,596 153,509
147,339 157,898

8. LIMIT OF MEMBERS' GUARANTEE

The liability of the members is limited. Every member of the company undertakes to contribute such amount as
may be required (not exceeding £1) to the company's assets if the company should be wound up while he is a
member or within one year after he ceases to be a member.